A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome

2016 ◽  
Vol 196 (3) ◽  
pp. 747-754 ◽  
Author(s):  
J. Curtis Nickel ◽  
Blair Egerdie ◽  
Edward Davis ◽  
Robert Evans ◽  
Lloyd Mackenzie ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document